Pitch Workshop / Silicon Valley War Stories @ CEMS / WU Wien 5/3/13Hansjoerg Posch
The (slightly revised) slides for the Pitch Workshop I held at the International Management/CEMS program of the WU Vienna in spring 2013. I was really impressed by the questions of the students about running a startup and hope that some of them will follow the entrepreneurial paths in the future :)
Startup Essentials is the ultimate startup experience. We care about one thing: startups only matter if they make money from real customers. Participants in Startup Essentials Bootcamp will create new startups, issue and sell shares, find investors and take the company to the public markets.
As a participant, in three days you will:
- Validate your business model
- Buy and sell startup's shares
- Grow your startup
- Take your startup to the IPO
New U at ONA in Atlanta : October 2013 : "Startup Mythbusting" : Presentation...Harry Lin
Do I need a business plan? Will my friends work for free? I’ll make money from advertising, right? Is it better to work at a failed startup than to never have worked at one at all? We’ll answer your questions, too. An interactive discussion at the NewU Startup Bootcamp at ONA.
Pitch Workshop / Silicon Valley War Stories @ CEMS / WU Wien 5/3/13Hansjoerg Posch
The (slightly revised) slides for the Pitch Workshop I held at the International Management/CEMS program of the WU Vienna in spring 2013. I was really impressed by the questions of the students about running a startup and hope that some of them will follow the entrepreneurial paths in the future :)
Startup Essentials is the ultimate startup experience. We care about one thing: startups only matter if they make money from real customers. Participants in Startup Essentials Bootcamp will create new startups, issue and sell shares, find investors and take the company to the public markets.
As a participant, in three days you will:
- Validate your business model
- Buy and sell startup's shares
- Grow your startup
- Take your startup to the IPO
New U at ONA in Atlanta : October 2013 : "Startup Mythbusting" : Presentation...Harry Lin
Do I need a business plan? Will my friends work for free? I’ll make money from advertising, right? Is it better to work at a failed startup than to never have worked at one at all? We’ll answer your questions, too. An interactive discussion at the NewU Startup Bootcamp at ONA.
Towards a Truly Healthy Life: Behavior Design for Lifestyle Changetaralv
An intensive four patient case study on patents with chronic illnesses. Through our Stanford University class in the design school (d.school), we worked with these patients to create personalized plans for lifestyle change.
We tested the hypothesis that macromolecular agents will have a greater sensitivity in identifying areas of high regional mammary tumor permeability-surface area products than low molecular weight agents. New modalities such as ultrasound, MRI, and nuclear medicine may improve breast cancer diagnosis(1). MRI can detect small tumors, 1 mm, with nearly 100% sensitivity(2) and can differentiate benign from malignant tumors with an accuracy of only 30 to 40%(3). A need exists for more accurately characterizing tumor specificity with MR mammography. Dynamic contrast enhanced MR mammography shows promise, and is based on differences in capillary density. Only a subset of tumor cells acquire angiogenic activity and this results in heterogeneous capillary density and surface area(4). High regional capillary density indicates poor prognosis(5). Tumor secreted factors induce angiogenesis, including vascular endothelial growth factor (VEGF), which is necessary for metastasis and regions high in VEGF exhibit hyperpermeability(6). Some of the physiological byproducts of angiogenesis regulate the extraction of an agent by a tumor from the blood. This extraction depends on (a) capillary surface area, S, (b) capillary permeability, P, (c) capillary blood flow, F, (d) transit time of the agent through the tumor interstitium, and (e) the plasma half-life, T1/2 DIST(7, 8). By imaging the time evolution of a contrast agent in the lesion, one can model agent extraction. Knowing the plasma half-life of an agent and regional blood flow provides a measure of the capillary surface area and permeability. Such knowledge may provide a means of differentiating benign from malignant tumors.
My presentation on the paper: Xen and the Art of Virtualization by Paul Barham, Boris Dragovic, Keir Fraser, Steven Hand, Tim Harris, Alex Ho, Rolf Neugebauer, Ian Pratt, Andrew Warfield. Prepared for CSCI 297 - Advanced Operating System at GWU, Spring 2010
Towards a Truly Healthy Life: Behavior Design for Lifestyle Changetaralv
An intensive four patient case study on patents with chronic illnesses. Through our Stanford University class in the design school (d.school), we worked with these patients to create personalized plans for lifestyle change.
We tested the hypothesis that macromolecular agents will have a greater sensitivity in identifying areas of high regional mammary tumor permeability-surface area products than low molecular weight agents. New modalities such as ultrasound, MRI, and nuclear medicine may improve breast cancer diagnosis(1). MRI can detect small tumors, 1 mm, with nearly 100% sensitivity(2) and can differentiate benign from malignant tumors with an accuracy of only 30 to 40%(3). A need exists for more accurately characterizing tumor specificity with MR mammography. Dynamic contrast enhanced MR mammography shows promise, and is based on differences in capillary density. Only a subset of tumor cells acquire angiogenic activity and this results in heterogeneous capillary density and surface area(4). High regional capillary density indicates poor prognosis(5). Tumor secreted factors induce angiogenesis, including vascular endothelial growth factor (VEGF), which is necessary for metastasis and regions high in VEGF exhibit hyperpermeability(6). Some of the physiological byproducts of angiogenesis regulate the extraction of an agent by a tumor from the blood. This extraction depends on (a) capillary surface area, S, (b) capillary permeability, P, (c) capillary blood flow, F, (d) transit time of the agent through the tumor interstitium, and (e) the plasma half-life, T1/2 DIST(7, 8). By imaging the time evolution of a contrast agent in the lesion, one can model agent extraction. Knowing the plasma half-life of an agent and regional blood flow provides a measure of the capillary surface area and permeability. Such knowledge may provide a means of differentiating benign from malignant tumors.
My presentation on the paper: Xen and the Art of Virtualization by Paul Barham, Boris Dragovic, Keir Fraser, Steven Hand, Tim Harris, Alex Ho, Rolf Neugebauer, Ian Pratt, Andrew Warfield. Prepared for CSCI 297 - Advanced Operating System at GWU, Spring 2010